Lincoln Pharmaceuticals Limited

Lincoln Pharma reports Best-Ever Results in a Financial Year; Reports Highest Revenue, EBIDTA, Net Profit in FY22

Company recommends 15% dividend, Rs. 1.50 per share for FY 22  FY22 Results Highlights:- (Standalone) ·         Net Profit Reports Y-o-Y…

3 years ago

Lincoln Pharmaceuticals Ltd plans to launch Cephalosporin products soon; Acquires a plant in Mehsana, Gujarat

Acquisition funded from Internal accruals; Expects turnover of Rs. 150 crore in next 3 years Highlights:- Investment in Cephalosporin plant…

3 years ago

Lincoln Pharmaceuticals Ltd reports 28.33% rise in the Standalone Net Profit at Rs.11.85 crore in Q4 FY21

Company recommends dividend of 15% - Rs. 1.5 per share for FY 21 Net Revenues from operations in Q4FY21 at…

4 years ago

Lincoln Pharmaceuticals Ltd reports 16.70% rise in the Standalone Net Profit at Rs. 35.19 crore in H1 FY21

Company to expand export network to 90 plus countries post EU approval; Becomes a Zero net-debt company  Net revenues in…

4 years ago

Lincoln Pharmaceuticals Ltd reports 23% rise in the Standalone Net Profit at Rs.14.99 crore in Q1FY21

Becomes a Zero net-debt company paying its outstanding debt to the Financial Institution Net revenues in Q1FY21 at Rs. 103.01…

4 years ago

Lincoln Pharmaceuticals Ltd reports Net Profit of Rs. 10.92 crore, up19.47% in Q3FY2019-20

New Delhi, February 14, 2020: Net revenues for Q3FY20 at Rs. 101.5 crore, up 19.7% as compared to Rs. 84.8…

5 years ago